Dystocia and Cesarean Section

Dystocia is defined as difficult or abnormal parturition, characterized by failure of the dam to deliver a fetus through the birth canal within a normal time frame or without assistance. It is a common obstetric emergency in small animal practice, particularly in brachycephalic and toy breeds. Cesarean section (hysterotomy) is the surgical intervention used to deliver fetuses when vaginal delivery is impossible, contraindicated, or has failed. The procedure involves an incision into the uterus (hysterotomy) through a ventral midline celiotomy, followed by extraction of all fetuses and closure of the uterine incision. Cesarean section is a life-saving procedure for both the dam and the neonates and requires careful perioperative management to optimize maternal and neonatal outcomes. The surgical approach, timing, and technique are critical to minimize maternal morbidity and neonatal mortality.

The etiology of dystocia is multifactorial and can be classified into maternal and fetal causes. Maternal causes include uterine inertia (primary or secondary), which is the most common cause in dogs and cats, often associated with uterine overdistension, metabolic derangements (hypocalcemia, hypoglycemia), or systemic illness. Obstructive maternal causes include pelvic canal abnormalities (e.g., pelvic fractures, congenital narrowing), vaginal or vulvar strictures, neoplasia, or uterine torsion. Fetal causes include fetal oversize (relative or absolute), fetal malpresentation (e.g., breech, transverse), fetal malformation (e.g., hydrocephalus, schistosomus reflexus), or fetal death with emphysema. In brachycephalic breeds, fetal oversize is common due to large fetal head size relative to the maternal pelvis. Cesarean section is indicated when medical management (e.g., oxytocin, calcium) fails or when there is an absolute obstruction. Iatrogenic causes may include inappropriate use of oxytocin leading to uterine rupture or fetal distress.

Dystocia is a common emergency in small animal practice, with an incidence of approximately 5% in dogs and 1% in cats. Breed predispositions include brachycephalic breeds (e.g., English Bulldog, French Bulldog, Boston Terrier) due to fetal oversize and narrow pelvic canal, and toy breeds (e.g., Chihuahua, Yorkshire Terrier) due to small litter size and large fetal head. In cats, Persian and Siamese breeds may have higher risk. Dystocia is more common in primiparous dams and in those with small litters (one or two fetuses) due to fetal oversize. Cesarean section is performed in approximately 60-80% of dystocia cases in dogs and cats. Maternal age over 6 years and obesity are additional risk factors. Working dogs may have higher risk due to physical exertion during pregnancy, but this is not well documented.

The pathophysiology of dystocia involves failure of the expulsive forces (uterine contractions) or obstruction of the birth canal. Uterine inertia can be primary, where the uterus fails to contract effectively from the onset of labor, or secondary, resulting from uterine muscle fatigue after prolonged ineffective contractions against an obstruction. Metabolic factors such as hypocalcemia (decreased myometrial contractility) and hypoglycemia (reduced energy supply) contribute to uterine inertia. Obstructive dystocia leads to fetal distress, hypoxia, and death if not relieved. Uterine torsion or rupture can cause maternal shock, hemorrhage, and peritonitis. In cesarean section, the surgical stress response, anesthesia, and manipulation of the uterus can lead to maternal hypotension, hypoxemia, and neonatal depression. The surgical incision into the uterus disrupts the placental blood supply, necessitating rapid fetal extraction to minimize hypoxia. Postoperative complications include uterine hemorrhage, peritonitis, and delayed wound healing.

Intrinsic factors include breed conformation (brachycephalic, toy breeds), maternal age (primiparous or elderly), obesity, small litter size, and genetic predisposition to uterine inertia. Extrinsic factors include nutritional deficiencies (calcium, glucose), lack of prenatal care, trauma, and iatrogenic factors such as inappropriate oxytocin administration. Prior cesarean sections may lead to uterine scarring and increased risk of uterine rupture. Environmental stress, such as changes in environment or excessive handling, can also precipitate dystocia. In working dogs, excessive exercise during late pregnancy may contribute to uterine inertia.

Clinical signs of dystocia include prolonged gestation (>72 days in dogs, >68 days in cats), visible straining for more than 30-60 minutes without delivery, presence of a dark green or bloody vaginal discharge, fetal membranes visible at the vulva for more than 15 minutes, and signs of maternal distress such as restlessness, panting, depression, or vomiting. On physical examination, the dam may be febrile, tachycardic, or hypotensive. Abdominal palpation may reveal a fetus in the birth canal or an abnormally shaped uterus. Vaginal examination may identify fetal malpresentation, pelvic obstruction, or vaginal stricture. In cases of uterine rupture, signs of shock and peritonitis may be present. Neonates may be stillborn or weak, with bradycardia and poor Apgar scores.

Differential diagnoses for dystocia include: 1) Normal parturition with prolonged interstage interval (physiological rest) - distinguished by normal fetal heart rates and no maternal distress. 2) Abdominal pregnancy (extrauterine pregnancy) - rare, but may present with abdominal pain and lack of labor. 3) Uterine torsion - acute abdominal pain, shock, and lack of progression. 4) Uterine rupture - severe shock, hemoperitoneum, and fetal death. 5) Vaginal or vulvar neoplasia - may cause obstruction, identified on vaginal exam or imaging. 6) Pelvic fractures - history of trauma, palpation, and radiography. 7) Fetal malformation (e.g., hydrocephalus) - may cause obstruction, identified on ultrasound or radiography. 8) Primary uterine inertia - no obstruction, but lack of effective contractions. 9) Secondary uterine inertia - history of prolonged straining with obstruction. 10) Systemic illness (e.g., hypocalcemia, sepsis) - may cause weakness and lack of labor.

The diagnostic algorithm for dystocia begins with a thorough history and physical examination, including assessment of maternal vital signs and vaginal examination (with sterile gloves and lubricant) to identify fetal presentation and any obstructions. If vaginal delivery is not imminent, perform abdominal radiography to evaluate fetal number, size, position, and any maternal pelvic abnormalities. Ultrasonography is essential to assess fetal viability (heart rate, movement) and placental integrity. If fetal distress is detected (fetal heart rate <180 bpm in dogs, <200 bpm in cats) or if there is no progression, consider medical management with calcium gluconate (10% solution, 0.5-1.5 mL/kg IV slowly) and oxytocin (0.5-2 IU/dog, 0.25-1 IU/cat IM) if no obstruction is present. If medical management fails or if there is an obstruction, proceed with cesarean section. Preoperative blood work (CBC, biochemistry, electrolytes, glucose, calcium) and coagulation profile are recommended to identify metabolic abnormalities and assess surgical risk.

Laboratory findings in dystocia may include hypocalcemia (ionized calcium <1.0 mmol/L), hypoglycemia (<60 mg/dL), and elevated lactate due to maternal stress. Complete blood count may show leukocytosis with a left shift if infection is present. Biochemistry may reveal elevated liver enzymes or azotemia if there is concurrent disease. Coagulation panel (PT, aPTT, platelet count) is important to assess bleeding risk, especially if uterine rupture is suspected. Blood gas analysis may show metabolic acidosis in cases of prolonged labor. Inflammatory biomarkers such as C-reactive protein (CRP) may be elevated in cases of metritis or peritonitis. Synovial fluid analysis is not relevant in this condition.

Radiography is the primary imaging modality for dystocia. It can determine fetal number, position (cranial, caudal, transverse), and size relative to the maternal pelvis. Fetal skull width and maternal pelvic canal diameter can be measured to predict dystocia. Radiographic signs of fetal death include overlapping skull bones (Spalding sign), gas in the fetal abdomen, or collapse of the spine. Ultrasonography is used to assess fetal viability by detecting fetal heartbeats and movement. It can also evaluate placental separation and uterine wall integrity. In cases of suspected uterine torsion or rupture, abdominal ultrasound may show free fluid or abnormal uterine architecture. Advanced imaging such as CT or MRI is rarely needed but may be used to evaluate pelvic fractures or neoplasia. Fluoroscopy can be used during assisted vaginal delivery but is not commonly available.

Cytology and histopathology are not typically used in the diagnosis of dystocia. However, if a uterine mass or neoplasia is suspected, fine-needle aspiration or biopsy may be performed. Vaginal cytology may be used to assess the stage of estrus but is not helpful in dystocia. Histopathology of the uterus after cesarean section may be performed if there is evidence of infection, necrosis, or neoplasia. In cases of uterine rupture, histopathology may reveal inflammation, hemorrhage, and tissue necrosis.

Treatment of dystocia begins with medical management if no obstruction is present and fetal viability is confirmed. Medical management includes correction of hypocalcemia (10% calcium gluconate, 0.5-1.5 mL/kg IV over 10-20 minutes with ECG monitoring) and hypoglycemia (dextrose 0.5-1 g/kg IV). Oxytocin (0.5-2 IU/dog, 0.25-1 IU/cat IM) may be administered 30 minutes after calcium, but should not be used if there is an obstruction or if uterine rupture is suspected. If medical management fails or if there is an obstruction, cesarean section is indicated. Preoperative stabilization includes IV fluids (lactated Ringer's solution at 10-20 mL/kg/h), oxygen supplementation, and correction of metabolic abnormalities. Anesthesia protocols should minimize neonatal depression: epidural anesthesia (lidocaine 2%, 1 mL/4.5 kg) combined with a light plane of general anesthesia (e.g., propofol induction, isoflurane maintenance) is preferred. The surgical technique involves a ventral midline celiotomy from the umbilicus to the pubis. The uterus is exteriorized and packed off with laparotomy sponges. A single midline incision is made on the ventral surface of the uterine body, extending towards the horns, avoiding the placental sites. Each fetus is delivered by gentle traction, and the umbilical cord is clamped and cut. The placenta is removed if easily detached; otherwise, it is left to be expelled postpartum. After all fetuses are delivered, the uterine incision is closed in two layers: a simple continuous pattern using absorbable monofilament suture (e.g., polydioxanone, 3-0 or 4-0) for the mucosa-submucosa, and a continuous Lembert or Cushing pattern for the seromuscular layer. The abdomen is lavaged with warm sterile saline and closed routinely. Postoperative care includes analgesia (opioids, NSAIDs), antibiotics (if indicated), and monitoring for hemorrhage and infection. Neonates should be resuscitated immediately, including clearing airways, drying, and providing warmth.

The prognosis for dystocia treated with cesarean section is generally good for the dam, with a maternal mortality rate of less than 5% when performed promptly. Neonatal survival rates range from 80-95% if surgery is performed within 24 hours of the onset of dystocia, but decrease significantly with prolonged labor or fetal distress. Prognostic indicators include the duration of dystocia, fetal viability at presentation, and the presence of maternal complications such as uterine rupture or sepsis. Negative prognostic factors include prolonged labor (>24 hours), fetal death, and maternal systemic illness. With appropriate perioperative care, most dams recover fully and can have future pregnancies, although repeat cesarean sections may be necessary in breeds with conformational predispositions.

Postoperative follow-up includes monitoring the dam for signs of hemorrhage, infection, or uterine involution. The skin sutures or staples are removed 10-14 days after surgery. The dam should be restricted from vigorous activity for 2 weeks. Incision site should be checked daily for swelling, discharge, or dehiscence. The dam's appetite, temperature, and vaginal discharge should be monitored. A recheck examination is recommended at 2 weeks and 4 weeks postoperatively to assess healing and uterine involution. If the dam is to be bred again, it is recommended to wait at least one estrous cycle to allow complete healing. Neonates should be monitored for weight gain and nursing behavior. If any complications arise, such as metritis or peritonitis, additional treatment may be required.

Pearls: 1) Always assess fetal viability before deciding on medical vs. surgical management. 2) Use epidural anesthesia to reduce neonatal depression. 3) Exteriorize the uterus carefully to avoid contamination. 4) Make the uterine incision on the ventral surface to avoid major blood vessels. 5) Deliver fetuses quickly to minimize hypoxia. 6) Close the uterus in two layers to ensure a watertight seal. 7) Administer oxytocin after surgery to aid uterine involution and milk let-down. Pitfalls: 1) Delaying surgery in cases of obstruction can lead to fetal and maternal death. 2) Using oxytocin in cases of obstruction can cause uterine rupture. 3) Inadequate preoperative stabilization can lead to maternal hypotension and neonatal depression. 4) Failure to remove all fetuses and placentas can lead to metritis. 5) Poor suture technique can lead to uterine dehiscence and peritonitis. 6) Inadequate neonatal resuscitation can increase neonatal mortality.

Perioperative drug protocols based on Plumb's Veterinary Drug Handbook: 1) Preoperative: Cefazolin (22 mg/kg IV) or ampicillin (20 mg/kg IV) administered 30 minutes before incision, repeated every 90 minutes during surgery if needed. 2) Analgesia: Opioids such as hydromorphone (0.05-0.1 mg/kg IV) or buprenorphine (0.01-0.02 mg/kg IV) for intraoperative and postoperative pain. NSAIDs such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) can be used postoperatively if no contraindications. 3) Local anesthesia: Epidural lidocaine (2%, 1 mL/4.5 kg) or bupivacaine (0.5%, 1 mL/4.5 kg) for intraoperative analgesia. 4) Oxytocin (0.5-2 IU/dog, 0.25-1 IU/cat IM) postoperatively to promote uterine involution and milk let-down. 5) Calcium gluconate (10%, 0.5-1.5 mL/kg IV slowly) if hypocalcemia is present. 6) Dextrose (0.5-1 g/kg IV) if hypoglycemia is present. 7) Antibiotics: Continue cefazolin or ampicillin for 24 hours postoperatively if contamination occurred. 8) For neonates: Doxapram (1-2 drops sublingual) may be used to stimulate respiration if needed.

Key studies and guidelines: 1) A retrospective study by Darvelid and Linde-Forsberg (1994) reported that cesarean section in dogs had a maternal mortality rate of 1.4% and a neonatal mortality rate of 11.6%, with higher neonatal mortality associated with prolonged dystocia. 2) A study by Moon et al. (2001) compared anesthesia protocols for cesarean section and found that epidural anesthesia combined with propofol induction and isoflurane maintenance resulted in better neonatal Apgar scores compared to other protocols. 3) The ACVS (American College of Veterinary Surgeons) consensus statement on cesarean section recommends prompt surgical intervention if medical management fails or if fetal distress is present. 4) A study by Smith (2005) evaluated the use of oxytocin in dystocia and concluded that it should only be used in cases of primary uterine inertia without obstruction. 5) A meta-analysis by Traas (2008) on neonatal resuscitation after cesarean section emphasized the importance of immediate airway clearance, drying, and thermal support. 6) The ECVS (European College of Veterinary Surgeons) guidelines recommend routine use of perioperative antibiotics in cesarean section to reduce the risk of metritis. 7) A prospective study by Fieni et al. (2010) found that postoperative administration of oxytocin improved uterine involution and reduced the incidence of retained placenta.